InvestorsObserver
×
News Home

Lixte Biotechnology Holdings Inc (LIXT) Down 6.82% in Premarket Trading

Thursday, March 28, 2024 06:59 AM | InvestorsObserver Analysts

Mentioned in this article

Lixte Biotechnology Holdings Inc (LIXT) Down 6.82% in Premarket Trading

Lixte Biotechnology Holdings Inc (LIXT) is lower by Thursday morning, with the stock decreasing -6.82% in pre-market trading to 3.28. LIXT's short-term technical score of 36 indicates that the stock has traded less bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 104 out of 146 industries, LIXT ranks higher than 51% of stocks. Lixte Biotechnology Holdings Inc has risen 59.28% over the past month, closing at $2.60 on February 29. During this period of time, the stock fell as low as $2.20 and as high as $2.72.

Overall Score - 23
LIXT has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on LIXT!
Lixte Biotechnology Holdings Inc has a Long-Term Technical rank of 31. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 69% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, LIXT ranks better than 69% of stocks.

Important Dates for Investors in LIXT:

-Lixte Biotechnology Holdings Inc is set to release earnings on 2024-05-08. Over the last 12 months, the company has reported EPS of $-3.27. -We do not have a set dividend date for Lixte Biotechnology Holdings Inc at this time. Click Here To Get The Full Report on Lixte Biotechnology Holdings Inc (LIXT)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App